Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1EPRATUZUMAB
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
2Epratuzumab 100 mg
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
3Epratuzumab 1200 mg
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
4Epratuzumab 400 mg
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
5Epratuzumab 600 mg
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
6Epratuzumab iv
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
7Epratuzumab sc
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬
8HLL2 (Epratuzumab)
(D04036)		1件: Epratuzumab1件: Epratuzumab (D04036) 💬1件: CD22 💬3件: B cell receptor signaling pathway, Cell adhesion molecules, Hematopoietic cell lineage 💬1件: 49 💬